Heart Failure Patients Have New Treatment Option as Morton Plant Hospital Joins Clinical Trial
CLEARWATER, Fla., (July 25, 2013)? Morton Plant Hospital is the first hospital in the southeastern United States to participate in a clinical trial designed to treat heart failure patients whose ventricle has enlarged and who, until this time, had limited treatment options. The PARACHUTE IV trial will test a minimally invasive catheter-based device called the Parachute(R) Ventricular Partitioning Device.
“We are excited to offer a minimally invasive therapy for patients who have sustained significant heart damage caused by blocked arteries,” said Patrick Cambier, MD, a Morton Plant Mease interventional cardiologist and Principal Investigator. “Morton Plant Hospital is one of the first of 15 hospitals in the entire country participating in this treatment.”
After a heart attack, many heart failure patients experience enlargement of their left ventricle, one of the lower chambers of the heart. The weakened heart cannot supply enough blood, resulting in heart failure symptoms such as fatigue and shortness of breath. Treatment options for patients whose ventricles are enlarged are limited.
The Parachute device offers the first minimally invasive catheter-based treatment to partition the damaged muscle, excluding the non-functional area of the heart from the healthy portion to decrease overall volume of the left ventricle and restore the shape and function of the heart.
Through a small catheter inserted in the femoral artery, the Parachute implant is deployed in the left chamber of the heart. This minimally invasive procedure is performed in the catheterization lab under conscious sedation.
Once the device is in place, the arms of the device anchor into the wall of the heart to hold it in position. About six months after the Parachute device has been implanted, tissue will cover the device, and it will become permanent. Because it is permanent, it will not need to be replaced or adjusted.
For more information, contact Morton Plant Hospital’s Clinical Research Department, (727) 461-8519.
About Morton Plant Hospital
Established in 1916, Morton Plant Hospital is a 687-bed facility. Our commitment to improving the health of everyone we serve is reflected in our community partnerships and many honors. Morton Plant is the only hospital in the United States to have been awarded Top 100 Hospital designations by the Thomson Reuters 100 Top Hospitals: National Benchmarks for Success for a consecutive 13 years. Other hospital honors include: Magnet Designation for the second time by the American Nurses Credentialing Center, the most prestigious national recognition of excellence in nursing care, “Baby-Friendly” hospital status from the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) for its efforts to support mothers’ decision to breast feed and received Florida Hospitals Association’s Innovation of the Year in Patient Care award. Morton Plant Hospital is located at 300 Pinellas Street, Clearwater, Fla. For more information about Morton Plant Hospital, call (727) 953-6877.
About BayCare Health System
BayCare Health System is a leading community-based health system in the Tampa Bay area. Composed of a network of 10 not-for-profit hospitals, outpatient facilities and services such as imaging, lab, behavioral health and home health care, BayCare provides expert medical care throughout a patient’s lifetime. With more than 200 access points conveniently located throughout Tampa Bay, BayCare connects patients to a complete range of preventive, diagnostic and treatment services for any health care need.
BayCare’s family of hospitals are: Mease Countryside, Mease Dunedin, Morton Plant, Morton Plant North Bay, St. Anthony’s, St. Joseph’s, St. Joseph’s Children’s, St. Joseph’s Hospital-North, St. Joseph’s Women’s, and South Florida Baptist. For more information, visit BayCare on the Web at www.BayCare.org.